↑ Rising
Business
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
The European Medicines Agency's CHMP has issued a positive opinion recommending Eli Lilly's Jaypirca for the treatment of chronic lymphocytic leukemia.